• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CRISPR/Cas9介导的肌萎缩侧索硬化症患者诱导多能干细胞中的靶向基因校正

CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs.

作者信息

Wang Lixia, Yi Fei, Fu Lina, Yang Jiping, Wang Si, Wang Zhaoxia, Suzuki Keiichiro, Sun Liang, Xu Xiuling, Yu Yang, Qiao Jie, Belmonte Juan Carlos Izpisua, Yang Ze, Yuan Yun, Qu Jing, Liu Guang-Hui

机构信息

National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, 100101, China.

State Key Laboratory of Stem Cell and Reproductive Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, 100101, China.

出版信息

Protein Cell. 2017 May;8(5):365-378. doi: 10.1007/s13238-017-0397-3. Epub 2017 Apr 11.

DOI:10.1007/s13238-017-0397-3
PMID:28401346
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5413600/
Abstract

Amyotrophic lateral sclerosis (ALS) is a complex neurodegenerative disease with cellular and molecular mechanisms yet to be fully described. Mutations in a number of genes including SOD1 and FUS are associated with familial ALS. Here we report the generation of induced pluripotent stem cells (iPSCs) from fibroblasts of familial ALS patients bearing SOD1 and FUS mutations, respectively. We further generated gene corrected ALS iPSCs using CRISPR/Cas9 system. Genome-wide RNA sequencing (RNA-seq) analysis of motor neurons derived from SOD1 and corrected iPSCs revealed 899 aberrant transcripts. Our work may shed light on discovery of early biomarkers and pathways dysregulated in ALS, as well as provide a basis for novel therapeutic strategies to treat ALS.

摘要

肌萎缩侧索硬化症(ALS)是一种复杂的神经退行性疾病,其细胞和分子机制尚未完全阐明。包括超氧化物歧化酶1(SOD1)和融合蛋白(FUS)在内的多个基因的突变与家族性ALS相关。在此,我们报告了分别从携带SOD1和FUS突变的家族性ALS患者的成纤维细胞中诱导生成多能干细胞(iPSC)。我们还使用CRISPR/Cas9系统生成了基因校正的ALS-iPSC。对源自SOD1和校正后的iPSC的运动神经元进行全基因组RNA测序(RNA-seq)分析,发现了899个异常转录本。我们的工作可能有助于发现ALS中失调的早期生物标志物和通路,并为治疗ALS的新治疗策略提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/592d/5413600/6ac6f3e1454f/13238_2017_397_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/592d/5413600/d5d6475328de/13238_2017_397_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/592d/5413600/a48bec443a53/13238_2017_397_Fig2a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/592d/5413600/a88b4aded3ef/13238_2017_397_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/592d/5413600/6ac6f3e1454f/13238_2017_397_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/592d/5413600/d5d6475328de/13238_2017_397_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/592d/5413600/a48bec443a53/13238_2017_397_Fig2a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/592d/5413600/a88b4aded3ef/13238_2017_397_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/592d/5413600/6ac6f3e1454f/13238_2017_397_Fig4_HTML.jpg

相似文献

1
CRISPR/Cas9-mediated targeted gene correction in amyotrophic lateral sclerosis patient iPSCs.CRISPR/Cas9介导的肌萎缩侧索硬化症患者诱导多能干细胞中的靶向基因校正
Protein Cell. 2017 May;8(5):365-378. doi: 10.1007/s13238-017-0397-3. Epub 2017 Apr 11.
2
CRISPR/Cas9-Mediated Gene Correction to Understand ALS.CRISPR/Cas9 介导的基因校正以了解肌萎缩侧索硬化症。
Int J Mol Sci. 2020 May 27;21(11):3801. doi: 10.3390/ijms21113801.
3
A streamlined CRISPR workflow to introduce mutations and generate isogenic iPSCs for modeling amyotrophic lateral sclerosis.一种简化的 CRISPR 工作流程,用于引入突变并生成用于肌萎缩侧索硬化症建模的同基因 iPSC。
Methods. 2022 Jul;203:297-310. doi: 10.1016/j.ymeth.2021.09.002. Epub 2021 Sep 6.
4
ALS-causing mutations differentially affect PGC-1α expression and function in the brain vs. peripheral tissues.导致肌萎缩侧索硬化症的突变对大脑与外周组织中PGC-1α表达和功能的影响存在差异。
Neurobiol Dis. 2017 Jan;97(Pt A):36-45. doi: 10.1016/j.nbd.2016.11.001. Epub 2016 Nov 3.
5
Gene Therapy in Amyotrophic Lateral Sclerosis.肌萎缩侧索硬化症的基因治疗。
Cells. 2022 Jun 29;11(13):2066. doi: 10.3390/cells11132066.
6
Genetic Correction of SOD1 Mutant iPSCs Reveals ERK and JNK Activated AP1 as a Driver of Neurodegeneration in Amyotrophic Lateral Sclerosis.SOD1 突变诱导多能干细胞的基因矫正揭示 ERK 和 JNK 激活的 AP1 是肌萎缩性侧索硬化症神经退行性变的驱动因素。
Stem Cell Reports. 2017 Apr 11;8(4):856-869. doi: 10.1016/j.stemcr.2017.02.019. Epub 2017 Mar 30.
7
Establishment of In Vitro FUS-Associated Familial Amyotrophic Lateral Sclerosis Model Using Human Induced Pluripotent Stem Cells.利用人诱导多能干细胞建立体外 FUS 相关性肌萎缩侧索硬化症模型。
Stem Cell Reports. 2016 Apr 12;6(4):496-510. doi: 10.1016/j.stemcr.2016.02.011. Epub 2016 Mar 17.
8
Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.周细胞延长肌萎缩侧索硬化症 SOD1 小鼠的存活时间,并在该疾病的啮齿动物模型和源自肌萎缩侧索硬化症患者的诱导性多能干细胞衍生的神经元细胞中诱导抗氧化酶的表达。
Stem Cell Rev Rep. 2017 Oct;13(5):686-698. doi: 10.1007/s12015-017-9752-2.
9
Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations.肌萎缩侧索硬化症(ALS)患者诱导多能干细胞衍生运动神经元中的钙动力学和谷氨酸受体特性改变,与 C9orf72、FUS、SOD1 或 TDP43 突变有关。
Hum Mol Genet. 2019 Sep 1;28(17):2835-2850. doi: 10.1093/hmg/ddz107.
10
The fused in sarcoma protein forms cytoplasmic aggregates in motor neurons derived from integration-free induced pluripotent stem cells generated from a patient with familial amyotrophic lateral sclerosis carrying the FUS-P525L mutation.在携带FUS-P525L突变的家族性肌萎缩侧索硬化症患者所产生的无整合诱导多能干细胞衍生的运动神经元中,肉瘤融合蛋白形成细胞质聚集体。
Neurogenetics. 2015 Jul;16(3):223-31. doi: 10.1007/s10048-015-0448-y. Epub 2015 Apr 26.

引用本文的文献

1
An iPSC-derived neuronal model reveals manganese's role in neuronal endocytosis, calcium flux and mitochondrial bioenergetics.一种诱导多能干细胞衍生的神经元模型揭示了锰在神经元内吞作用、钙通量和线粒体生物能量学中的作用。
iScience. 2025 Aug 6;28(9):113311. doi: 10.1016/j.isci.2025.113311. eCollection 2025 Sep 19.
2
CRISPR/Cas9 a genomic engineering technology for treatment in ALS mouse models.CRISPR/Cas9:一种用于治疗肌萎缩侧索硬化症小鼠模型的基因组编辑技术。
Regen Ther. 2025 Aug 13;30:575-583. doi: 10.1016/j.reth.2025.07.009. eCollection 2025 Dec.
3
Targets and Gene Therapy of ALS (Part 1).

本文引用的文献

1
Visualization of aging-associated chromatin alterations with an engineered TALE system.利用工程化TALE系统可视化衰老相关的染色质改变。
Cell Res. 2017 Apr;27(4):483-504. doi: 10.1038/cr.2017.18. Epub 2017 Jan 31.
2
FUS Mislocalization and Vulnerability to DNA Damage in ALS Patients Derived hiPSCs and Aging Motoneurons.肌萎缩侧索硬化症(ALS)患者来源的诱导多能干细胞(hiPSC)及衰老运动神经元中FUS的错误定位与对DNA损伤的易感性
Front Cell Neurosci. 2016 Dec 26;10:290. doi: 10.3389/fncel.2016.00290. eCollection 2016.
3
In vivo genome editing via CRISPR/Cas9 mediated homology-independent targeted integration.
肌萎缩侧索硬化症的治疗靶点与基因治疗(第一部分)
Int J Mol Sci. 2025 Apr 25;26(9):4063. doi: 10.3390/ijms26094063.
4
A bibliometric analysis of gene editing and amyotrophic lateral sclerosis (from 2004 to 2024).基因编辑与肌萎缩侧索硬化症的文献计量分析(2004年至2024年)
Front Neurosci. 2024 Nov 26;18:1499025. doi: 10.3389/fnins.2024.1499025. eCollection 2024.
5
In vivo and ex vivo gene therapy for neurodegenerative diseases: a promise for disease modification.用于神经退行性疾病的体内和体外基因治疗:疾病修饰的希望。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Oct;397(10):7501-7530. doi: 10.1007/s00210-024-03141-4. Epub 2024 May 22.
6
Advancements in CRISPR-Based Therapies for Genetic Modulation in Neurodegenerative Disorders.基于 CRISPR 的神经退行性疾病遗传调控疗法的进展。
Curr Gene Ther. 2024;25(1):34-45. doi: 10.2174/0115665232292246240426125504.
7
Discovery of a novel homozygous SOD1 truncating variant bolsters infantile SOD1 deficiency syndrome.发现一种新型的 SOD1 截短变异体,进一步支持婴儿型 SOD1 缺乏症。
Mol Biol Rep. 2024 Apr 26;51(1):580. doi: 10.1007/s11033-024-09513-6.
8
Development of novel treatments for amyotrophic lateral sclerosis.肌萎缩侧索硬化症新型疗法的研发。
Metab Brain Dis. 2024 Mar;39(3):467-482. doi: 10.1007/s11011-023-01334-z. Epub 2023 Dec 11.
9
Transcriptome driven discovery of novel candidate genes for human neurological disorders in the telomer-to-telomer genome assembly era.端粒到端粒基因组组装时代人类神经紊乱新型候选基因的转录组学发现。
Hum Genomics. 2023 Oct 23;17(1):94. doi: 10.1186/s40246-023-00543-y.
10
Recent Advances in CRISPR/Cas9 Delivery Approaches for Therapeutic Gene Editing of Stem Cells.CRISPR/Cas9 递送方法在干细胞治疗性基因编辑中的最新进展。
Stem Cell Rev Rep. 2023 Nov;19(8):2576-2596. doi: 10.1007/s12015-023-10585-3. Epub 2023 Sep 18.
通过CRISPR/Cas9介导的同源性非依赖靶向整合进行体内基因组编辑。
Nature. 2016 Dec 1;540(7631):144-149. doi: 10.1038/nature20565. Epub 2016 Nov 16.
4
Activation of HIPK2 Promotes ER Stress-Mediated Neurodegeneration in Amyotrophic Lateral Sclerosis.HIPK2的激活促进肌萎缩侧索硬化症中内质网应激介导的神经退行性变。
Neuron. 2016 Jul 6;91(1):41-55. doi: 10.1016/j.neuron.2016.05.021. Epub 2016 Jun 16.
5
Vitamin C alleviates aging defects in a stem cell model for Werner syndrome.维生素C可缓解沃纳综合征干细胞模型中的衰老缺陷。
Protein Cell. 2016 Jul;7(7):478-88. doi: 10.1007/s13238-016-0278-1. Epub 2016 Jun 6.
6
Repression of the Antioxidant NRF2 Pathway in Premature Aging.过早衰老中抗氧化剂NRF2信号通路的抑制
Cell. 2016 Jun 2;165(6):1361-1374. doi: 10.1016/j.cell.2016.05.017.
7
Modulation of Matrix Metalloproteinases Activity in the Ventral Horn of the Spinal Cord Re-stores Neuroglial Synaptic Homeostasis and Neurotrophic Support following Peripheral Nerve Injury.脊髓腹角中基质金属蛋白酶活性的调节可恢复周围神经损伤后神经胶质突触稳态和神经营养支持。
PLoS One. 2016 Mar 30;11(3):e0152750. doi: 10.1371/journal.pone.0152750. eCollection 2016.
8
Establishment of In Vitro FUS-Associated Familial Amyotrophic Lateral Sclerosis Model Using Human Induced Pluripotent Stem Cells.利用人诱导多能干细胞建立体外 FUS 相关性肌萎缩侧索硬化症模型。
Stem Cell Reports. 2016 Apr 12;6(4):496-510. doi: 10.1016/j.stemcr.2016.02.011. Epub 2016 Mar 17.
9
Looking Inside the Matrix: Perineuronal Nets in Plasticity, Maladaptive Plasticity and Neurological Disorders.深入剖析神经基质:神经元周围网在可塑性、适应性不良可塑性及神经系统疾病中的作用
Neurochem Res. 2016 Jul;41(7):1507-15. doi: 10.1007/s11064-016-1876-2. Epub 2016 Mar 2.
10
Modeling xeroderma pigmentosum associated neurological pathologies with patients-derived iPSCs.利用患者来源的诱导多能干细胞建立色素性干皮病相关神经病理学模型。
Protein Cell. 2016 Mar;7(3):210-21. doi: 10.1007/s13238-016-0244-y. Epub 2016 Feb 13.